John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$153M |
| 2 |
Target
TGT
|
+$106M |
| 3 |
Altria Group
MO
|
+$74.3M |
| 4 |
Coca-Cola
KO
|
+$70.3M |
| 5 |
Procter & Gamble
PG
|
+$62.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$233M |
| 2 |
McDonald's
MCD
|
+$214M |
| 3 |
Autodesk
ADSK
|
+$196M |
| 4 |
Johnson & Johnson
JNJ
|
+$193M |
| 5 |
HP
HPQ
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.18% |
| 2 | Technology | 11.08% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Consumer Staples | 8.4% |
| 5 | Financials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
PUT
Designer Brands
DBI
$290M
| $135K | ﹤0.01% |
27,100
+14,600
| +117% | +$189K |
|
2777
Lineage Cell Therapeutics
LCTX
$283M
| $135K | ﹤0.01% |
162,633
-191,072
| -54% | -$190K |
|
2778
CALL
Lands' End
LE
$374M
| $135K | ﹤0.01% |
25,200
+13,600
| +117% | +$146K |
|
2779
BlackBerry
BB
$4.57B
| $134K | ﹤0.01% |
32,416
-693,246
| -96% | -$3.77M |
|
2780
MakeMyTrip
MMYT
$5.56B
| $134K | ﹤0.01% |
11,223
-12,200
| -52% | -$264K |
|
2781
Natural Health Trends
NHTC
$14.7M
| $133K | ﹤0.01% |
40,475
-44,926
| -53% | -$182K |
|
|
TGI
2782
DELISTED
Triumph Group
TGI
| $133K | ﹤0.01% |
19,694
-97,372
| -83% | -$1.78M |
|
2783
PUT
TechnipFMC
FTI
$29.7B
| $131K | ﹤0.01% |
26,208
+9,005
| +52% | +$98.8K |
|
2784
Great Elm Capital Corp
GECC
$83.2M
| $131K | ﹤0.01% |
7,827
-8,698
| -53% | -$347K |
|
|
NPKI
2785
NPK International
NPKI
$1.12B
| $131K | ﹤0.01% |
+146,174
| New | +$548K |
|
|
GRTS
2786
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $131K | ﹤0.01% |
22,548
+6,798
| +43% | +$57.1K |
|
|
JAX
2787
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $131K | ﹤0.01% |
34,109
-26,615
| -44% | -$217K |
|
2788
Unisys
UIS
$190M
| $130K | ﹤0.01% |
10,537
-90,014
| -90% | -$1.15M |
|
|
PCTI
2789
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $130K | ﹤0.01% |
19,520
-77,056
| -80% | -$586K |
|
2790
Carter Bankshares
CARE
$729M
| $129K | ﹤0.01% |
14,095
-12,225
| -46% | -$209K |
|
|
KG
2791
Kestrel Group
KG
$58.3M
| $129K | ﹤0.01% |
7,078
-10,843
| -61% | -$184K |
|
|
WPX
2792
CALL
DELISTED
WPX Energy, Inc.
WPX
| $129K | ﹤0.01% |
42,400
+15,200
| +56% | +$143K |
|
2793
PUT
Levi Strauss
LEVI
$8.25B
| $128K | ﹤0.01% |
+10,300
| New | +$182K |
|
|
MRO
2794
PUT
DELISTED
Marathon Oil Corporation
MRO
| $128K | ﹤0.01% |
39,000
+4,700
| +14% | +$43.3K |
|
2795
CALL
Adient
ADNT
$1.46B
| $127K | ﹤0.01% |
14,000
-10,100
| -42% | -$203K |
|
2796
Corcept Therapeutics
CORT
$13B
| $125K | ﹤0.01% |
+10,554
| New | +$131K |
|
2797
MediciNova
MNOV
$72.8M
| $125K | ﹤0.01% |
+33,639
| New | +$175K |
|
|
CPLG
2798
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $125K | ﹤0.01% |
31,993
-123,513
| -79% | -$976K |
|
|
2799
PUT
Adient
ADNT
$1.46B
| $124K | ﹤0.01% |
13,700
+2,700
| +25% | +$54.4K |
|
|
NOVA
2800
DELISTED
Sunnova Energy
NOVA
| $123K | ﹤0.01% |
+12,196
| New | +$167K |
|
Similar funds
John Overdeck's Q1 2020 Portfolio in Review
As of Q1 2020, John Overdeck held 4,183 positions worth $12.3B, down 63% from $33.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
John Overdeck withdrew a net $15.4B in Q1 2020, closing 1,188 positions and reducing 1,576 holdings. Its most notable exit was Johnson & Johnson, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $148M.
- John Overdeck's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,200,000 shares worth $148M.
- John Overdeck added most to Target in Q1 2020, an estimated $106M increase.
- John Overdeck's biggest Q1 2020 reduction was eBay, cutting an estimated $233M.
- John Overdeck fully exited Johnson & Johnson in Q1 2020, selling an estimated $193M.
- John Overdeck's ten largest holdings make up 11% of its $12.3B portfolio in Q1 2020.
- John Overdeck opened 588 new positions and closed 1,188 in Q1 2020.
- John Overdeck's portfolio value fell 63% quarter-over-quarter to $12.3B.
Based on Two Sigma Investments's 13F filing for Q1 2020, filed 15 May 2020.